Literature DB >> 7948207

Porcine parvovirus associated with cutaneous lesions in piglets.

K M Lager1, W L Mengeling.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7948207     DOI： 10.1177/104063879400600313

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN： 1040-6387            Impact factor:   1.279


× No keyword cloud information.
  7 in total

1.  Idiopathic vesicular disease in swine in Manitoba.

Authors:  Tim Pasma; Suzanne Davidson; Sheryl L Shaw
Journal:  Can Vet J       Date:  2008-01       Impact factor: 1.008

2.  The epitope of the VP1 protein of porcine parvovirus.

Authors:  Hong-ling Xie; Zhao Wang; Shang-jin Cui; Chao-fan Zhang; Yu-dong Cui
Journal:  Virol J       Date:  2010-07-16       Impact factor: 4.099

3.  The anti-porcine parvovirus activity of nanometer propolis flavone and propolis flavone in vitro and in vivo.

Authors:  Xia Ma; Zhenhuan Guo; Zhiqiang Shen; Yonglu Liu; Jinliang Wang; Yunpeng Fan
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-26       Impact factor: 2.629

4.  Real-Time Reverse Transcription PCR Assay for Detection of Senecavirus A in Swine Vesicular Diagnostic Specimens.

Authors:  Alexa J Bracht; Emily S O'Hearn; Andrew W Fabian; Roger W Barrette; Abu Sayed
Journal:  PLoS One       Date:  2016-01-12       Impact factor: 3.240

Review 5.  Possible risks posed by single-stranded DNA viruses of pigs associated with xenotransplantation.

Authors:  Anbu K Karuppannan; Tanja Opriessnig
Journal:  Xenotransplantation       Date:  2018-07       Impact factor: 3.907

Review 6.  Concurrent infections are important for expression of porcine circovirus associated disease.

Authors:  Tanja Opriessnig; Patrick G Halbur
Journal:  Virus Res       Date:  2011-09-16       Impact factor: 3.303

Review 7.  Increasing diversity of swine parvoviruses and their epidemiology in African pigs.

Authors:  Kayode Olayinka Afolabi; Benson Chuks Iweriebor; Anthony Ifeanyi Okoh; Larry Chikwelu Obi
Journal:  Infect Genet Evol       Date:  2019-04-30       Impact factor: 3.342
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.